forum

LAURUSLABS Share Price Discussion

Laurus Labs Ltd.
Sector: Pharmaceuticals and health care
... Read more
LAURUSLABS Share Price *
341.1 -0.15 (-0.04%)
* (quote may be delayed)

LAURUSLABS Discussion Forum

Laurus Labs gains 3% on EIR from USFDA for Vizag units
Laurus Labs is among the three companies to receive an approval for TLE 400, an antiretroviral therapy product
Moneycontrol
Like
reply
Reply
share
Share
Lovable Lingeri Standalone June 2019 Net Sales at Rs 52.58 crore, down 4.21% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share

HDFC Securities is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August 05, 2019.
Like
reply
Reply
share
Share
Buy Laurus Labs; target of Rs 470: HDFC Securities
HDFC Securities is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August 05, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Laurus Labs Q1: Impacted by transition in ARV-API business; strong traction in formulation is positive
moneycontrol.com
Like
reply
Reply
share
Share
Stocks in the news: ITC, RIL, Nestle, NIIT, Coffee Day, DHFL, Union Bank, Bata India, JK Cement
Nestle India | NIIT | Coffee Day Enterprises | DHFL | Union Bank | Bata India and JK Cement are stocks which are in the news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
Trade Setup for Monday: Top 15 things to know before Opening Bell
Jimeet Modi of SAMCO Securities said volatility has increased giving intraday traders good opportunities provided they are on the right side of the market
www.moneycontrol.com
Like
reply
Reply
share
Share
Laurus Labs Q1 PAT down 9% at Rs 15 Cr
Satyanarayana Chava CEO said the API (Active Pharmaceutical Ingredients) Generics business witnessed a slowdown mainly because of lower ARV (antiretroviral) and Hepatitis C API sales.
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • LAURUSLABS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,254.94
    Enterprise Value5,170.37
    Price to Earnings30.81
    Price to Book Value2.68
    Return on Capital Employed0.13
    Return on Equity0.11
    Face Value10
    Dividend YieldNA
  • LAURUSLABS Share Price - Technicals

    keyboard_arrow_down
    LAURUSLABS - 52 Week High₹446
    LAURUSLABS - 52 Week Low₹314.05
  • LAURUSLABS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    5-Aug-19HDFC SecuritiesBuy471
    17-Jul-19HDFC SecuritiesBuy515
    1-Jul-19Kotak SecuritiesBuy430
    6-May-19Motilal OswalBuy470
    26-Apr-19HDFC SecuritiesBuy417
    View all LAURUSLABS - Share Targets - Broker Reports
  • LAURUSLABS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 16335345335341.05
    Sep 13343.25344337.05341.25
    Sep 12345348342.9343.95
    Sep 11351.1353.45344.4346.1
    Sep 9344.9355344351.1
  • LAURUSLABS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹335.53
    30 Day Moving Average₹334.16
    50 Day Moving Average₹338.63
    100 Day Moving Average₹351.3
    200 Day Moving Average₹361.69
  • LAURUSLABS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,039.291,891.920.08
    Operating Profit408.75415.62-0.02
    Profit Before Tax240.91247.63-0.03
    Net Income173.14202.57-0.15
  • LAURUSLABS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,5901,513.30.05
    Total Liabilities1,7271,612.410.07
    Total Assets3,3183,125.710.06
  • LAURUSLABS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity368.6320.060.15
    Cash from Investing Activity-417.48-280.950.49
    Cash from Financing Activity48.99-47.31-2.04
    Net Cash Flow0.12-8.21-1.01
  • LAURUSLABS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.060.08
    Return on Equity0.110.15
    Return on Capital Employed0.130.16
  • LAURUSLABS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.54
    3 Year CAGR Growth in Operating Profit0.99
    3 Year CAGR Growth in EBIDTA0.83
    3 Year CAGR Growth in Net Income1.36
    3 Yr CAGR Growth - Diluted EPS0.82
  • LAURUSLABS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.82
    5 Year CAGR Growth in Operating Profit1.82
    5 Year CAGR Growth in EBIDTA1.92
    5 Year CAGR Growth in Net Income0.96
    3 Yr CAGR Growth - Diluted EPS0.44
  • LAURUSLABS Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 5 4:38 PM
    Laurus Labs gains 3% on EIR from USFDA for Vizag units
    Moneycontrol
    NewsBot
    Aug 12 9:28 PM
    Lovable Lingeri Standalone June 2019 Net Sales at Rs 52.58 crore, down 4.21% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 7 10:53 PM
    Buy Laurus Labs; target of Rs 470: HDFC Securities
    moneycontrol.com
    NewsBot
    Aug 6 7:28 PM
    Laurus Labs Q1: Impacted by transition in ARV-API business; strong traction in formulation is positive
    moneycontrol.com
    NewsBot
    Aug 5 1:13 PM
    Stocks in the news: ITC, RIL, Nestle, NIIT, Coffee Day, DHFL, Union Bank, Bata India, JK Cement
    www.moneycontrol.com
    NewsBot
    Aug 5 12:33 AM
    Trade Setup for Monday: Top 15 things to know before Opening Bell
    www.moneycontrol.com
    NewsBot
    Aug 3 12:48 AM
    Laurus Labs Q1 PAT down 9% at Rs 15 Cr
    moneycontrol.com
    NewsBot
    Jul 17 7:08 PM
    NewsBot
    Jun 17 4:43 PM
    NewsBot
    Jun 17 1:13 PM
  • LAURUSLABS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.